Deals & IPOs

JBS to Buy Flora for $542 Million, Entering Personal Care

JBS will acquire Flora for $542 million, paying $367 million in equity through treasury Class A shares or Brazilian depositary receipts, while a separate $11 million Canal Rural deal broadens its reach.

By Nathan Brooks

3 min read

JBS Announces $542 Million Flora Acquisition To Enter Personal Care Market
JBS Announces $542 Million Flora Acquisition To Enter Personal Care Marketsilviarita / pixabay

What's News

  • JBS agreed to acquire Flora for $542 million, with assumed debt included.
  • $367 million of equity consideration is payable in treasury Class A shares, Brazilian depositary receipts or both.
  • JBS expects no change in net leverage, citing Flora’s earnings and the deal structure.
  • Flora generated R$2.9 billion, about $531 million, in annual net revenue for the 12 months ended September 2026.
  • The Flora deal and $11 million Canal Rural acquisition are expected to close in December 2026, subject to customary conditions.

By Nathan Brooks

JBS agreed to acquire Brazilian consumer-products company Flora for $542 million, entering beauty and personal care while adding a household cleaning operation. JBS said the deal provides an established platform in adjacent consumer categories beyond its global food portfolio.

Flora is owned by J&F Group, JBS’s controlling shareholder. JBS said the transaction brings a business from its controlling shareholder into the company. For readers, this is a purchase from the shareholder that already controls JBS, rather than from an unrelated seller.

Under JBS’s announced terms, the $542 million purchase price includes assumed debt. JBS will pay $367 million of equity consideration entirely through treasury Class A shares, Brazilian depositary receipts or a combination of both. Put another way, roughly two-thirds of the headline price takes the form of equity, while JBS assumes the debt included in the transaction.

JBS expects no change to its net leverage ratio, based on Flora’s earnings contribution and the transaction structure. For shareholders, the central assumption is that Flora’s earnings will offset the addition of acquired assets, leaving net borrowing leverage unchanged.

What does this change for JBS?

It broadens JBS’s operating mix into beauty, personal care and household cleaning. JBS reported that Flora generated R$2.9 billion, approximately $531 million, in annual net revenue for the 12 months ended September 2026. The acquired business gives JBS a scaled consumer platform rather than a small product line or an early-stage venture.

JBS said it intends to connect its ingredients and collagen capabilities with Flora’s brands, distribution network and consumer-products expertise. The acquisition complements Genu-in, established in 2022 to develop collagen applications, and research activities at JBS Biotech and BioTech Foods. Together, those assets connect JBS’s upstream research with Flora’s consumer reach and product expertise.

JBS identified Minuano, Francis, Neutrox and OX as Flora’s brands. JBS said Flora operates five factories, seven distribution centers and a research and development center. Flora employs more than 4,200 people, giving JBS manufacturing capacity and a distribution base alongside the acquired brands.

Flora originated as JBS’s hygiene and cleaning division before separating in 2007, JBS said. The businesses have maintained commercial ties, including JBS’s supply of beef tallow for cleaning and hygiene products. The acquisition reconnects a former division with its former parent and extends both businesses beyond their original split.

A second deal adds Brazilian agribusiness media

JBS separately agreed to acquire Canal Rural for $11 million on a cash-free, debt-free basis, the company said. Canal Rural is an agribusiness-focused Brazilian media company. JBS will adjust the final purchase price for closing net debt, leaving part of the transaction’s final economics dependent on the balance sheet at closing.

Both acquisitions are expected to close in December 2026, subject to customary conditions. Flora’s revenue figure covers the 12 months ended September 2026, three months before the planned close. That timing puts the integration test close to the transaction date.

For JBS shareholders, the near-term test is whether Flora’s brands and distribution reach can be combined with JBS’s ingredient and collagen capabilities without altering the unchanged leverage profile JBS expects. The first post-close balance sheet will test whether the consumer expansion remains financially neutral on that measure.

Canal Rural adds a separate agribusiness-media asset, with its final valuation still dependent on closing net debt. If the deals close as expected in December, the first post-close balance sheet will test JBS’s stated expectation: more consumer exposure without higher net leverage.

Source: pulse2.com

Share this article:

More from Nathan Brooks

Nathan Brooks

Show full bio

News editor covering regulation, policy and their impact on entrepreneurship, startups and venture funding at Business Bearings.

2,232 articles

Related articles

« Previous articleNext article »